Department of Plastic, Reconstructive and Aesthetic Surgery, Toyama University Hospital, Toyama, Japan.
Department of Plastic and Reconstructive Surgery, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan.
Microsurgery. 2022 Jul;42(5):441-450. doi: 10.1002/micr.30861. Epub 2022 Jan 5.
In some breast cancer patients with a contralateral unaffected hypertrophic and ptotic breast, autologous small-breast reconstruction with contralateral breast reduction is a good option. The current study is aimed to assess the efficacy of the double-pedicle unaffected split-breast (USB) flap harvested from the central half of the unaffected breast for unilateral breast reconstruction with contralateral transverse scar reduction mammoplasty.
Between February 2003 and May 2020, 14 patients underwent breast reconstruction using the USB flap. The mean patient age was 59.1 (range: 48-76) years, and the mean body mass index was 24.2 (range: 19.5-33.3) kg/m . This flap comprised half of the contralateral breast tissues with the 3rd or 4th internal mammary perforator (IMAP) and the lateral thoracic vessel (LTA/V). After USB flap elevation and LTA/V resection, flap perfusion from the IMAP was evaluated on indocyanine green (ICG) angiography. The medial pedicle USB flap was rotated 180° and was transferred to the affected site via the midline. The LTA/V was anastomosed to the recipient vessel to supercharge the distal part of the USB flap, which was then used for breast reconstruction. Then, the remaining contralateral upper and lower breast poles were used for transverse scar reduction mammoplasty.
The mean flap size was 13.3 × 26.9 (range: 9.5 × 22 to 16 × 29) cm. All flaps and reduced breasts survived without serious complications such as flap necrosis, although there was one patient with hematoma and one patient with hypertrophic scar. ICG revealed poor perfusion in the distal, lateral part of the flap, ranging from 22.0% to 48.5% of the overall flap area. Final aesthetic evaluation was high, with 11 cases (78.6%) being "good" or "excellent" and 3 cases (21.4%) that were either poor or fair. The mean follow-up period for the patients was 53.8 (range: 15-84) months, with none of the patients presenting second primary breast cancer or recurrence in both breasts.
USB flap breast reconstruction with contralateral reduction mammoplasty is a valuable option in breast cancer patients with a hypertrophic and ptotic breast.
在一些对侧未受影响的乳房肥大和下垂的乳腺癌患者中,自体小乳房重建联合对侧乳房缩小术是一种很好的选择。本研究旨在评估从未受影响乳房的中央半部分采集的双蒂未受影响的分体乳房(USB)皮瓣用于单侧乳房重建联合对侧横形瘢痕乳房缩小成形术的效果。
2003 年 2 月至 2020 年 5 月,14 例患者接受 USB 皮瓣乳房重建。患者平均年龄为 59.1(范围:48-76)岁,平均体重指数为 24.2(范围:19.5-33.3)kg/m2。该皮瓣包含对侧乳房组织的一半,带有第 3 或第 4 内乳动脉穿支(IMAP)和胸外侧血管(LTA/V)。USB 皮瓣抬起和 LTA/V 切除后,通过吲哚菁绿(ICG)血管造影评估 IMAP 皮瓣的灌注情况。将内侧蒂 USB 皮瓣旋转 180°,通过中线转移至受影响部位。将 LTA/V 吻合至受体血管以增强 USB 皮瓣的远端部分,然后用于乳房重建。然后,使用剩余的对侧上下乳房极用于横形瘢痕乳房缩小成形术。
平均皮瓣大小为 13.3×26.9(范围:9.5×22 至 16×29)cm。所有皮瓣和缩小的乳房均未出现严重并发症,如皮瓣坏死,尽管有 1 例患者出现血肿,1 例患者出现肥厚性瘢痕。ICG 显示皮瓣远端、外侧部分的灌注不良,占整个皮瓣面积的 22.0%至 48.5%。最终的美学评估结果较高,11 例(78.6%)为“良好”或“优秀”,3 例(21.4%)为“差”或“一般”。患者的平均随访时间为 53.8(范围:15-84)个月,无患者出现双侧乳腺癌的第二原发癌或复发。
USB 皮瓣乳房重建联合对侧乳房缩小术是乳房肥大和下垂的乳腺癌患者的一种有价值的选择。